These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 30137355

  • 1. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
    Lamb LS, Alfonso H, Norman PE, Davis TME, Forbes J, Müench G, Irrgang F, Almeida OP, Golledge J, Hankey GJ, Flicker L, Yeap BB.
    J Clin Endocrinol Metab; 2018 Nov 01; 103(11):4224-4231. PubMed ID: 30137355
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study.
    Barzilay JI, Bůžková P, Zieman SJ, Kizer JR, Djoussé L, Ix JH, Tracy RP, Siscovick DS, Cauley JA, Mukamal KJ.
    J Bone Miner Res; 2014 Nov 01; 29(5):1061-6. PubMed ID: 24877243
    [Abstract] [Full Text] [Related]

  • 6. Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men.
    Siru R, Alfonso H, Chubb SAP, Golledge J, Flicker L, Yeap BB.
    Clin Endocrinol (Oxf); 2018 Jul 01; 89(1):93-99. PubMed ID: 29655173
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Response to Letter to the Editor: "Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men".
    Lamb LS, Davis TME, Forbes J, Irrgang F, Golledge J, Flicker L, Yeap BB.
    J Clin Endocrinol Metab; 2019 Mar 01; 104(3):684-685. PubMed ID: 30351368
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
    Scavello F, Tedesco CC, Castiglione S, Maciag A, Sangalli E, Veglia F, Spinetti G, Puca AA, Raucci A.
    Biomark Med; 2021 Aug 01; 15(11):785-796. PubMed ID: 34236256
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
    Yamamoto M, Yamaguchi T, Yamauchi M, Sugimoto T.
    Diabetes Care; 2009 Dec 01; 32(12):2263-8. PubMed ID: 19752174
    [Abstract] [Full Text] [Related]

  • 13. Proportion of Undercarboxylated Osteocalcin and Serum P1NP Predict Incidence of Myocardial Infarction in Older Men.
    Yeap BB, Alfonso H, Chubb SA, Byrnes E, Beilby JP, Ebeling PR, Allan CA, Schultz C, Hankey GJ, Golledge J, Flicker L, Norman PE.
    J Clin Endocrinol Metab; 2015 Oct 01; 100(10):3934-42. PubMed ID: 26308289
    [Abstract] [Full Text] [Related]

  • 14. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
    Neumann T, Lodes S, Kästner B, Franke S, Kiehntopf M, Lehmann T, Müller UA, Wolf G, Sämann A.
    Osteoporos Int; 2014 May 01; 25(5):1527-33. PubMed ID: 24599273
    [Abstract] [Full Text] [Related]

  • 15. The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and Infrainguinal Bypass Vein.
    Malmstedt J, Frebelius S, Lengquist M, Jörneskog G, Wang J, Swedenborg J.
    Eur J Vasc Endovasc Surg; 2016 Apr 01; 51(4):579-86. PubMed ID: 26905625
    [Abstract] [Full Text] [Related]

  • 16. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
    Semba RD, Ferrucci L, Fink JC, Sun K, Beck J, Dalal M, Guralnik JM, Fried LP.
    Am J Kidney Dis; 2009 Jan 01; 53(1):51-8. PubMed ID: 18789567
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.
    Perkins RK, Miranda ER, Karstoft K, Beisswenger PJ, Solomon TPJ, Haus JM.
    Nutrients; 2019 Mar 01; 11(3):. PubMed ID: 30823632
    [Abstract] [Full Text] [Related]

  • 20. Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease.
    Yang ZK, Shen Y, Shen WF, Pu LJ, Meng H, Zhang RY, Zhang Q, Chen QJ, De Caterina R, Lu L.
    Int J Cardiol; 2015 Oct 15; 197():241-7. PubMed ID: 26142969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.